Inflammatory Bowel Diseases

Cover image for Vol. 18 Issue 12

Edited By: Robert Burakoff, M.D., M.P.H and Richard P. MacDermott, M.D.

Impact Factor: 4.855

ISI Journal Citation Reports © Ranking: 2011: 12/74 (Gastroenterology & Hepatology)

Online ISSN: 1536-4844


Author Guidelines


NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.



Author Guidelines


SCOPE The focus of the journal Inflammatory Bowel Diseases® is to bring the most current information in the clinical and basic sciences to all physicians caring for patients with inflammatory bowel diseases, and to investigators performing research in inflammatory bowel diseases and related fields. The journal publishes peer-reviewed manuscripts and review articles in basic and clinical sciences, updates on clinical trials, reviews of the current literature, editorials, and other features.

ETHICAL/LEGAL CONSIDERATIONS A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of the publisher. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher. All manuscripts must be submitted online through the journal's website at http://mc.manuscriptcentral.com/ibd .

Patient Anonymity and Informed Consent - It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.

Copyright - A copy of the journal's ``Authorship Responsibility, Financial Disclosure, and Copyright Transfer'' form must be signed by all authors and submitted to the editorial receiving office.

Permissions - Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, and not the responsibility of the publisher.

PREPARATION OF MANUSCRIPT Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. (See specific guidelines for Letters to the Editor below.) For questions on preparing manuscripts for submission, please contact Julie Nash - nashj@hss.edu.

Title Page Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.

Structured Abstract and Key Words Limit the abstract to 250 words. It must be factual and comprehensive. Do not cite references in the abstract. Limit the use of abbreviations and acronyms, and avoid general statements (e.g., ``the significance of the results is discussed''). It should be sectioned into Background, Methods, Results, and Conclusions. List three to five key words.

Text For full-length research articles, organize the manuscript in the following sequence: Abstract and Key Words, Introduction, Materials and Methods, Ethical Considerations, Results, Discussion, Acknowledgment, References, Tables, and Figure Legends. Original Research Articles: Authors are encouraged to submit articles in basic or clinical science. Review Articles of exceptional merit will also be accepted. Contributors should communicate with the Editors before submitting a review. Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. Acknowledge all forms of support, including pharmaceutical industry support, in an Acknowledgment paragraph.

Abbreviations For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.

References The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication, personal communications, in parentheses in the text. If there are more than three authors, only name the first three authors and then use et al. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:

Journal Article 1. Gudlaugsdottir S, van Dekken H, Stijnen T, et al. Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis. J Clin Gastroenterol. 2002;34:536-540.

Book Chapter 2. Tobin RW, Kimmey MB. Painful diseases of the gastrointestinal tract. In: Loeser JD, ed. Bonica's Management of Pain. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1269-1292.

Entire Book 3. Rohen JW, Yokochi C, Lütjen-Drecoll E. Color Atlas of Anatomy: A Photographic Study of the Human Body. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.

Software 4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.

Online Journals 5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.

Database 6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.

World Wide Web 7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.

Figures Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), or an EPS (encapsulated postscript) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographsMradiographs, CT scans, and so onMand scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such as Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used. Cite figures consecutively on the site, and number them in the order in which they are discussed.

Figure Legends Legends must be submitted for all figures. They should be brief and specific, and they should appear after the text and before the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.

Color Figures The journal accepts for publication color figures that will enhance the article, and at the discretion of the Editors, figures may be printed in color for no additional charge. Otherwise, authors who submit color figures will receive an estimate of the cost for color reproduction. Figures are published online in color at no additional cost.

Tables Create tables using the table creating and editing feature of your word processing software (e.g., Word). Do not use Excel or comparable spreadsheet programs. Submit all tables as separate files. Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not imbed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.

Style Follow American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drugs, supplies, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.

Letters to the Editor Guidelines All LTEs will be published online-only, effective November 2010. All LTEs should start with the phrase ``To the Editors,'' and be written as a letter. There are to be no introduction, no abstract, and should include no more than 8 references.

REVISIONS
When submitting a revision, please submit both a clean copy and marked copy of the manuscript. The marked copy should highlight all of the changes made the by authors after the original review. Authors can use the track changes feature of the Microsoft Word program to create a marked copy. Authors also should submit all tables and figures in separate files for production purposes.

AFTER ACCEPTANCE
Page Proofs and Corrections Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading the files and for returning the corrected pages electronically to the publisher. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style should be allowed to stand if they do not alter the authors' meaning. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections returned within 24 to 48 hours of receipt, as requested in the communication accompanying the page proofs.

Reprints:

COMMERCIAL REPRINTS:
Email: corporatesaleseurope@wiley.com;
corporatesalesusa@wiley.com; or
corporatesalesaustralia@wiley.com

AUTHOR REPRINTS: (50-500 copies):
Order online: http://www.sheridanreprints.com/orderForm.html
Email:cjones@tsp.sheridan.com



Publisher's Contact - Journal Production
Return corrected page proofs, and any other related materials to:
Jessica Rodwick
John Wiley & Sons, Inc.
Email: ibdprod@wiley.com

SEARCH

SEARCH BY CITATION